Tag Archive | "Novartis"

Oxford BioMedica signs pharma licensing deal with Novartis

Tags: , ,

Oxford BioMedica has struck a pharma licensing deal worth $90 million with Novartis to manufacture goods that are needed for a highly experimental cancer research program. Read the full story

Pfizer signs a pharma deal with Novartis for two COPD drugs

Tags: , , ,

Pfizer has signed a pharma deal to promote two new drugs developed by Novartis. Read the full story

Novartis and TB Alliance sign a pharma licensing agreement

Tags: , , ,

Novartis has signed an exclusive worldwide pharma licensing agreement with the Global Alliance for TB Drug Development for compounds to fight tuberculosis that have been discovered at the Novartis Institutes for Tropical Diseases. Read the full story

Big pharma, Novartis sells LTS Lohmann for $400 million

Tags: , ,

Big pharma, Novartis and its partners have been trying to sell the skin-patch maker LTS Lohmann. Read the full story

Novartis creates pharma alliance with Banner Alzheimer’s Institute

Tags: , ,

Novartis announced a pharma alliance with Banner Alzheimer's Institute on a pioneering clinical study in Alzheimer's disease (AD) prevention. Read the full story

Novartis announces biotech partnering with Google

Tags: , , ,

Novartis has entered into a biotech partnering agreement with a division of Google to in-license its "smart lens" technology for all ocular medical uses. Read the full story

Top 50 Pharma (top pharmaceutical companies)

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story

Novartis enters into licensing deal with Ophthotech

Tags: , , ,

Novartis has acquired from Ophthotech exclusive rights to market the eye drug candidate Fovista outside the U.S., while retaining U.S. marketing rights, under a licensing deal and commercialization agreement that could net Opthotech more than $1 billion. Read the full story


Tags: , ,

Novartis is a top pharmaceutical company based in Basel, Switzerland Read the full story

Collaboration agreement for oncology drug candidates targeting apoptosis regulation pathways

Tags: , ,

Servier have signed a strategic global collaboration agreement with Novartis to develop and commercialize a series of novel drugs candidates issued from the Servier research programs partnered with Vernalis in oncology which are targeting the apoptosis regulation pathways. Read the full story